SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-12-000402
Filing Date
2012-03-16
Accepted
2012-03-16 12:19:33
Documents
11
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 lightlake10q013112.htm 10-Q 728816
2 ex31-1.htm EX-31.1 11939
3 ex31-2.htm EX-31.2 11601
4 ex32-1.htm EX-32.1 6435
5 ex32-2.htm EX-32.2 5929
  Complete submission text file 0001185185-12-000402.txt   2230386

Data Files

Seq Description Document Type Size
6 lltp-20120131.xml EX-101.INS 221828
7 lltp-20120131.xsd EX-101.SCH 16497
8 lltp-20120131_cal.xml EX-101.CAL 17894
9 lltp-20120131_def.xml EX-101.DEF 79047
10 lltp-20120131_lab.xml EX-101.LAB 102949
11 lltp-20120131_pre.xml EX-101.PRE 90244
Mailing Address 54 BAKER STREET 6TH FLOOR LONDON X0 W1U 7BU
Business Address 54 BAKER STREET 6TH FLOOR LONDON X0 W1U 7BU 44-207-034-1943
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-139915 | Film No.: 12696584
SIC: 1000 Metal Mining